4-methoxydalbergione

causes dermititis; RN given refers to cpd without isomeric designation

Also Known As:

2-methoxy-5-(1-phenylallyl)-4-benzoquinone; 2-methoxy-5-(1-phenylallyl)-p-benzoquinone; 4-methoxydalbergione, (R)-isomer; 4-methoxydalbergione, (S)-isomer

Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Quinones: 434
  - Benzoquinones: 25
    - 4-methoxydalbergione: 5

Experts

1.	Li, Ran: 2 articles (09/2021 - 01/2021)
2.	Chen, Di-Ling: 1 article (09/2021)
3.	Huang, Rong-Ni: 1 article (09/2021)
4.	Ji, Xiao-Yu: 1 article (09/2021)
5.	Li, Chun-Hui: 1 article (09/2021)
6.	Lin, Mian-Jie: 1 article (09/2021)
7.	Luo, Zhi-Hua: 1 article (09/2021)
8.	Ren, Qiu-Yun: 1 article (09/2021)
9.	Shen, Jian-Xin: 1 article (09/2021)
10.	Wu, Jie: 1 article (09/2021)

Related Diseases

1.	Liver Neoplasms (Liver Cancer) 10/13/2023 - "Identify GADD45G as a potential target of 4-methoxydalbergione in treatment of liver cancer: bioinformatics analysis and in vivo experiment." 01/01/2023 - "4-Methoxydalbergione Elicits Anticancer Effects by Upregulation of GADD45G in Human Liver Cancer Cells." 10/13/2023 - "Our previous studies have confirmed that GADD45G expression could be upregulated by 4-methoxydalbergione (4MOD) in liver cancer cells, but its potential pathological role in hepatocellular carcinoma (HCC) has not been fully understood. "
2.	Hepatocellular Carcinoma (Hepatoma) 10/13/2023 - "Our previous studies have confirmed that GADD45G expression could be upregulated by 4-methoxydalbergione (4MOD) in liver cancer cells, but its potential pathological role in hepatocellular carcinoma (HCC) has not been fully understood. "
3.	Osteosarcoma (Osteogenic Sarcoma) 02/09/2016 - "4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway." 09/01/2021 - "4-Methoxydalbergione (4MOD) is purified from Dalbergia sissoo Roxb., and shows an inhibitory effect on osteosarcoma, but its effects on astroglioma have not been reported. " 01/01/2021 - "4-Methoxydalbergione (4MOD), which is purified from Dalbergia sissoo Roxb, has been shown to have anticancer capacity for osteosarcoma and astroglioma. "
4.	Astrocytoma (Pilocytic Astrocytoma) 09/01/2021 - "4-Methoxydalbergione is a potent inhibitor of human astroglioma U87 cells in vitro and in vivo." 09/01/2021 - "4-Methoxydalbergione (4MOD) is purified from Dalbergia sissoo Roxb., and shows an inhibitory effect on osteosarcoma, but its effects on astroglioma have not been reported. " 01/01/2021 - "4-Methoxydalbergione (4MOD), which is purified from Dalbergia sissoo Roxb, has been shown to have anticancer capacity for osteosarcoma and astroglioma. "
5.	Urinary Bladder Neoplasms (Bladder Cancer) 01/01/2021 - "4-Methoxydalbergione Inhibits Bladder Cancer Cell Growth via Inducing Autophagy and Inhibiting Akt/ERK Signaling Pathway."